Pivotal Advance: Inhibition of HMGB1 nuclear translocation as a mechanism for the anti‐rheumatic effects of gold sodium thiomalate

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Leukocyte Biology

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1189/jlb.0507323PMID 17913975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis

  2007cited by this paper
• High mobility group box‐1 protein induces the migration and activation of human dendritic cells and acts as an alarmin

  2007influential reference
• HMGB1‐secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay

  2007cited by this paper
• Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis

  2007cited by this paper
• The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide.

  2006cited by this paper
• Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion1

  2006cited by this paper
• Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis.

  2006cited by this paper
• Alarmin(g) news about danger

  2006cited by this paper
• The extracellular release of HMGB1 during apoptotic cell death.

  2006cited by this paper
• NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

  2005cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.

  2003cited by this paper
• Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity.

  2003cited by this paper
• High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis.

  2003cited by this paper
• Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

  2003influential reference
• High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.

  2003cited by this paper
• Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.

  2002cited by this paper
• Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

  2002cited by this paper
• High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.

  2002cited by this paper
• RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

  2002cited by this paper
• The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway

  2002cited by this paper
• The double life of HMGB1 chromatin protein: architectural factor and extracellular signal

  2001cited by this paper
• New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

  2001cited by this paper
• Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase.

  2000cited by this paper
• Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase1

  2000cited by this paper
• Inhibition by auranofin of the production of prostaglandin E2 and nitric oxide in rat peritoneal macrophages.

  1999influential reference
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• [Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells].

  1996cited by this paper
• Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity.

  1994cited by this paper
• Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

  1992cited by this paper
• Auranofin modulated cytoplasmic free calcium in neutrophils by mobilizing intracellular calcium and inhibiting protein kinase.

  1990cited by this paper
• Identification of individual tumor necrosis factor/ cachectin‐producing cells after lipopolysaccharide induction

  1988cited by this paper

• HMGB1–Platelet Interactions: Mechanisms and Targeted Therapy Strategies

  2025cites this paper
• In-vitro and In-vivo screening methods for targeting HMBG1 in RA: A comprehensive overview

  2024cites this paper
• HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases

  2023cites this paper
• nanoGold and µGold inhibit autoimmune inflammation: a review

  2023cites this paper
• Inhibition of Local Inflammation by Implanted Gold: A Narrative Review of the History and Use of Gold

  2023cites this paper
• Metalloimmunotherapy with rhodium and ruthenium complexes: Targeting tumor-associated macrophages.

  2022cites this paper
• Goldimplantation: Neue Therapieform bei schmerzhafter Arthrose

  2021cites this paper
• Gold Compounds and the Anticancer Immune Response

  2021cites this paper
• The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases

  2021cites this paper
• Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis.

  2020cites this paper
• Recent Advances of Gold Compounds in Anticancer Immunity

  2020cites this paper
• Instructions for use Title Adiponectin Inhibits LPS-Induced HMGB 1 Release through an AMP Kinase and Heme Oxygenase-1-DependentPathway in RAW 264 Macrophage Cells

  2018cites this paper
• Redox-active trace metal-induced release of high mobility group box 1(HMGB1) and inflammatory cytokines in fibroblast-like synovial cells is Toll-like receptor 4 (TLR4) dependent.

  2018cites this paper
• High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.

  2018cites this paper
• Role of Redox-Active Trace Metal (RATM) Oxidants in the Regulation of Toll-Like Receptor 4 (TLR4) Signaling-Mediated Inflammatory Phenotype in Synovial Fibroblasts

  2018cites this paper
• High mobility group box protein 1 downregulates acid β-glucosidase 1 in synovial fibroblasts from patients with rheumatoid arthritis.

  2018cites this paper
• Metal Drugs and the Anticancer Immune Response.

  2018cites this paper
• Extracellular HMGB1 as a therapeutic target in inflammatory diseases

  2018cites this paper
• Post-translational modifications of high mobility group box 1 and cancer.

  2017cites this paper
• Effects of Gold Nanoparticles and Gold Anti-Arthritic Compounds on Inflammation Marker Expression in Macrophages

  2017cites this paper
• Advanced glycation end‐products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases

  2017cites this paper
• HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins

  2017cites this paper
• Adiponectin Inhibits LPS-Induced HMGB1 Release through an AMP Kinase and Heme Oxygenase-1-Dependent Pathway in RAW 264 Macrophage Cells

  2016influential citation
• Novel suppressive action of adiponectin on LPS- and HMGB1-induced inflammatory responses [an abstract of dissertation and a summary of dissertation review]

  2016cites this paper
• HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

  2016cites this paper
• Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.

  2015cites this paper
• A jack-of-all-trades: 2-mercaptosuccinic acid

  2015cites this paper
• High‐mobility group box‐1 in sterile inflammation

  2014cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• RAGE Expression and Serum HMGB 1 Levels in Rheumatoid Arthritis Patients and their Relations to Disease Activity

  2014cites this paper
• Extracellular High-Mobility Group Box 1 Protein (HMGB1) as a Mediator of Persistent Pain

  2014cites this paper
• Spinal HMGB1 induces TLR4‐mediated long‐lasting hypersensitivity and glial activation and regulates pain‐like behavior in experimental arthritis

  2014cites this paper
• Molecular mechanisms in idiopathic inflammatory myopathies

  2014cites this paper
• Cellular Injury and Apoptosis

  2014cites this paper
• Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models

  2013cites this paper
• The Dendritic Cell Response to Classic, Emerging, and Homeostatic Danger Signals. Implications for Autoimmunity

  2013cites this paper
• NANOCARRIERS FOR TARGETING IN INFLAMMATION

  2013cites this paper
• Multiple roles of HMGB1 in clinical and experimental arthritides

  2012cites this paper
• Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives.

  2012cites this paper
• Gene expression profiling of macrophages: implications for an immunosuppressive effect of dissolucytotic gold ions

  2012cites this paper
• HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

  2012cites this paper
• RAGE and its ligands in bone metabolism.

  2011cites this paper
• HMGB1 is a therapeutic target for sterile inflammation and infection.

  2011cites this paper
• Gold and Silver Complexes with Thiotriazoles and Thiotetrazoles

  2011cites this paper
• Haem oxygenase-1 down-regulates high mobility group box 1 and matrix metalloproteinases in osteoarthritic synoviocytes.

  2010cites this paper
• Immunomodulatory Drugs Regulate HMGB1 Release from Activated

  2010cites this paper
• Interactions of engineered and endogenous nanoparticles with cells in the immune system

  2010cites this paper
• Targeting HMGB1 in inflammation.

  2010cites this paper
• Immunomodulatory Drugs Regulate HMGB1 Release from Activated Human Monocytes

  2010cites this paper
• The role of HMGB1 in the pathogenesis of rheumatic disease.

  2010cites this paper
• Low‐dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality

  2009cites this paper
• Gold allergy : In vitro studies using peripheralblood mononuclear cells

  2009cites this paper
• Danger within : HMGB1 as a mediator of arthritis

  2008cites this paper
• HMGB1 AS A MEDIATOR OF ARTHRITIS

  2008cites this paper
• Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study

  2008cites this paper
• Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis

  2008cites this paper
• High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease

  2008cites this paper
• Characterisation of HMGB1 in inflammation

  2008cites this paper
• Circulating chromogranin A reveals extra‐articular involvement in patients with rheumatoid arthritis and curbs TNF‐α‐elicited endothelial activation

  2008cites this paper